Introduction
Plasma membrane receptors coupled to heterotrimeric G-proteins (GPCRs), a protein family with~1000 members, mediate a large variety of important physiological actions induced by hormones, neurotransmitters and sensory signals. At the cellular level, one of the major early events triggered by many GPCRs is the increase in intracellular free Ca 2ϩ concentration ([Ca 2ϩ ] i ). Since an
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© Oxford University Press increase in [Ca 2ϩ ] i is crucial for numerous cellular responses, it is of paramount importance to understand how GPCRs induce this early response. At present, the best-known Ca 2ϩ signalling pathway triggered by GPCRs, and also by tyrosine kinase receptors, is the activation of the phosphatidylinositol 4,5-bisphosphate-hydrolysing phospholipase C (PLC) which produces the Ca 2ϩ release second messenger, inositol 1,4,5-trisphosphate (IP 3 ) (Berridge, 1993; Clapham, 1995; Mikoshiba, 1997) . Different PLC isozymes have been identified which are activated by either tyrosine kinase receptors or GPCRs, apparently involving distinct G-protein α or βγ subunits (Cockcroft and Thomas, 1992; Lee and Rhee, 1995; Exton, 1996) . However, PLC-IP 3 -independent Ca 2ϩ mobilization by GPCRs has also been demonstrated. Examples include Ca 2ϩ signalling by α 2 -adrenoceptors (Michel et al., 1989) , neuropeptide Y receptors (Motulsky and Michel, 1988) , purinergic receptors (Frelin et al., 1993) , parathyroid hormone receptors (Seuwen and Boddeke, 1995) and thyrotropin-releasing hormone receptors (Tashjian et al., 1987) . Although there has been a long-standing search, the identity of the signalling pathway(s) and the second messenger(s) involved have remained elusive.
We have recently reported that Ca 2ϩ mobilization by the m2 muscarinic acetylcholine receptor (mAChR), a prototypical GPCR expressed in HEK-293 cells, is~50% pertussis toxin (PTX)-sensitive, whereas PLC stimulation is fully PTX-insensitive (Schmidt et al., 1995) . Furthermore, m2 mAChR-mediated Ca 2ϩ mobilization was not affected by Clostridium difficile toxin B, which, however, decreased receptor-mediated PLC stimulation markedly (Schmidt et al., 1996) . These observations suggested a PLC-independent Ca 2ϩ signalling by m2 mAChRs in HEK-293 cells. In search of the putative mechanism involved, we examined whether a Ca 2ϩ signalling pathway recently described for tyrosine kinase-linked receptors may also be used by GPCRs. Compared with the PLC-IP 3 pathway, this alternative Ca 2ϩ signalling pathway is thought to be triggered by activation of sphingosine kinase, resulting in the production of the Ca 2ϩ release second messenger, sphingosine-1-phosphate (SPP). The main evidence for this pathway is of three types (Beaven, 1996) . First, direct application of SPP to permeabilized DDT 1 MF-2 cells or microsomal preparations (Ghosh et al., 1990 (Ghosh et al., , 1994 and Swiss-3T3 cells causes a rapid release of Ca 2ϩ from internal stores in an IP 3 receptor-independent manner. Secondly, stimulation of platelet-derived growth factor (PDGF) receptors in a number of cell lines (Olivera and Spiegel, 1993; Bornfeldt et al., 1995) , as well as stimulation of FcεRI antigen receptors in RBL-2H3 mast cells (Choi et al., 1996) , activates sphingosine kinase, resulting in enhanced SPP production. Finally, micromolar concentrations of the sphingosine kinase inhibitor, DL-threo-dihydrosphingosine (DHS), markedly inhibit Ca 2ϩ signalling by these receptors, which either exhibit intrinsic tyrosine kinase activity (PDGF receptor) or are coupled to cytosolic protein tyrosine kinases (FcεRI antigen receptor).
Although previous data suggested that Ca 2ϩ mobilization by GPCRs, for example by the m1 mAChR, is independent of sphingosine kinase (Beaven, 1996; Choi et al., 1996) , we re-examined this issue, applying the criteria mentioned above, to establish the alternative Ca 2ϩ signalling pathway. Here we demonstrate that inhibition of sphingosine kinase markedly inhibits Ca 2ϩ signalling by mAChRs and other GPCRs in various cell types, that mAChR activation results in rapid production of SPP by sphingosine kinase, and that SPP acts as an intracellular Ca 2ϩ release agent in HEK-293 cells, thus strongly suggesting that the sphingosine kinase-SPP pathway represents an alternative Ca 2ϩ signalling pathway for mAChRs and other GPCRs.
Results
Inhibition of mAChR-mediated Ca 2⍣ signalling by sphingosine kinase inhibitors To test the hypothesis that m2 mAChR-induced Ca 2ϩ signalling involves the generation of SPP by sphingosine kinase, we first determined the effects of DHS and N,N-dimethylsphingosine (DMS), two membranepermeable sphingosine kinase inhibitors (Buehrer and Bell, 1992; Olivera et al., 1994; Yatomi et al., 1996) (Table  I) . Stimulation of m2 mAChR-expressing HEK-293 cells with a submaximally effective concentration of carbachol (100 μM) increased [Ca 2ϩ ] i by 447Ϯ132 nM (nϭ15) ( Figure 1A) . Pretreatment of the cells for 10 min with 30 μM DHS or 15 μM DMS inhibited the agonist-induced [Ca 2ϩ ] i increase by 74Ϯ4% and 79Ϯ9%, respectively (Figure 1B and C) . In contrast, N-acetylsphingosine (30 μM), which differs from DMS in having an -NHCOCH 3 group instead of an -N(CH 3 ) 2 group at C-2 and which does not inhibit sphingosine kinase at micromolar concentrations (Yatomi et al., 1996) , did not inhibit the carbachol-induced [Ca 2ϩ ] i increase ( Figure 1D) . Also, values of 20 and 7 μM are well within the ranges described (i.e. 5-50 μM for DHS and 5-10 μM for DMS) for inhibition of sphingosine kinase activity (Buehrer and Bell, 1992; Olivera and Spiegel, 1993; Olivera et al., 1994; Choi et al., 1996; Yatomi et al., 1996) . Complete inhibition of [Ca 2ϩ ] i increase elicited by 100 μM carbachol was observed in cells pretreated with 60 μM DHS or 30 μM DMS. Since Ca 2ϩ signalling by m2 mAChRs in HEK-293 cells is~50% PTX-insensitive (Schmidt et al., 1995) , these observations suggested that DHS and DMS inhibit PTX-sensitive, as well as PTX-insensitive, Ca 2ϩ mobilization. Indeed, DHS (30 μM) reduced [Ca 2ϩ ] i increase by carbachol (100 μM) in PTX-treated m2 mAChR-expressing cells by a magnitude (58Ϯ8%, nϭ3) similar to that seen in control cells.
For comparison, the effects of the sphingosine kinase inhibitors on Ca 2ϩ signalling were studied in HEK-293 cells expressing the highly efficient PLC stimulatory m3 mAChR. The mAChR-mediated [Ca 2ϩ ] i elevations in m3 and m2 mAChR-expressing cells are of comparable magnitude. However, m3 mAChR-mediated [Ca 2ϩ ] i increases are fully PTX-insensitive and mainly (almost 90%) due to Ca 2ϩ influx (Schmidt et al., 1995) . As the EC 50 values for carbachol for rising [Ca 2ϩ ] i in m3 mAChRexpressing HEK-293 cells are~100-fold lower than in m2 mAChR-expressing cells, we challenged m3 mAChRexpressing cells with 0.3 μM carbachol which, like 100 μM carbachol for m2 mAChRs, is a submaximally effective concentration (see below). Incubation with 0.3 μM carbachol increased [Ca 2ϩ ] i in m3 mAChR-expressing HEK-293 Recently, Putney and colleagues (Ribeiro et al., 1997) reported that disruption of the cytoskeleton abolishes Ca 2ϩ mobilization by ATP and PDGF in NIH 3T3 cells. However, treatment of m2 and m3 mAChR-expressing HEK-293 cells with cytochalasin B (10 μM, 1 h at 37°C) did not affect either the control carbachol-induced [Ca 2ϩ ] i increase or its inhibition by DHS (data not shown). Furthermore, a number of experiments were carried out to confirm that DHS and DMS did not deplete intracellular Ca 2ϩ stores. First, addition of DHS (30 μM) or DMS (15 μM) did not cause release of Ca 2ϩ from internal stores during a 10 min incubation period, as measured by fura-2 fluorescence. Secondly, a 10 min treatment with DHS (30 μM) or DMS (15 μM) did not reduce [Ca 2ϩ ] i elevations induced by the endoplasmic reticulum Ca 2ϩ -ATPase inhibitor, thapsigargin (2 μM) (nϭ3, data not shown). Thirdly, incubation of HEK-293 cells for 10 min with DHS (30 μM) did not reduce the cellular 45 Ca 2ϩ content of 45 Ca 2ϩ -preloaded cells (i.e. 98Ϯ2% of control cells), whereas the Ca 2ϩ ionophore, ionomycin (1 μM), decreased cellular 45 Ca 2ϩ by 76Ϯ3% (nϭ5) in the same period. The inhibitory action of DHS and DMS on Ca 2ϩ signalling in HEK-293 cells was not due to inhibition of carbachol-receptor interaction, as measured by N-[ 3 H]methylscopolamine-carbachol competition-binding experiments to m2 mAChR-expressing cells, or G-protein function, as determined by m2 mAChR-mediated inhibition of adenylyl cyclase. Furthermore, although DHS and DMS may act as protein kinase C inhibitors (Igarashi et al., 1989) , pretreatment of HEK-293 cells with the protein kinase C inhibitor, staurosporine (2 μM), for 30 min did not affect either m2 or m3 mAChR-induced [Ca 2ϩ ] i elevations (nϭ3) (data not shown). Importantly, inhibition of Ca 2ϩ signalling by DHS and DMS was not caused by diminished production of inositol phosphates. Pretreatment of HEK-293 cells for 10 min with 30 μM DHS or 15 μM DMS, causing a marked inhibition of Ca 2ϩ mobilization, did not inhibit production of IP 3 or total inositol phosphates in m2 and m3 mAChR-expressing cells stimulated with 100 μM and 0.3 μM carbachol, respectively (Figure 3) .
Recently, enhanced formation of cyclic ADP-ribose, apparently activating ryanodine-sensitive Ca 2ϩ channels, has been implicated as an alternative Ca 2ϩ signalling pathway for G-protein-coupled receptors. In membranes of NG108-15 neuroblastomaϫglioma hybrid cells, formation of cyclic ADP-ribose by ADP-ribosyl cyclase is activated by m1 and m3 mAChRs, while m2 and m4 mAChRs are inhibitory (Higashida et al., 1997 HEK-293 cells with 100 μM ryanodine for 30 min to block ryanodine receptors had no influence on m2 or m3 mAChR-stimulated [Ca 2ϩ ] i increases (data not shown).
To determine whether the contribution of the sphingosine kinase pathway in Ca 2ϩ signalling was dependent on the level of receptor stimulation, we studied the effect of DHS on m2 and m3 mAChR-mediated [Ca 2ϩ ] i rises at increasing carbachol concentrations (Figure 4) . In m2 mAChR-expressing HEK-293 cells, pretreatment with DHS (30 μM) reduced [Ca 2ϩ ] i increases by 50-70% at all carbachol concentrations. In contrast, inhibition of [Ca 2ϩ ] i elevation in m3 mAChR-expressing cells was clearly dependent on the degree of receptor stimulation. While DHS suppressed [Ca 2ϩ ] i increase in response to 0.1 μM carbachol by 50%, the inhibitory effect of DHS on [Ca 2ϩ ] i increase was reduced to only 15% at 10 μM carbachol and was lost completely at ജ100 μM carbachol in m3 mAChR-expressing cells.
Sphingosine kinase-mediated Ca 2⍣ signalling by various GPCRs
Besides mAChRs, other members of the superfamily of GPCRs were also found to utilize the sphingosine kinase pathway in a cell type-dependent manner. These included receptors which are endogenously expressed. As shown in Table II (Table II) . In conclusion, the contribution of sphingosine kinase to GPCR-mediated Ca 2ϩ signalling is apparently dependent both on the respective receptor and the respective cell type. (Table III) . These results indicate that sphingosine kinase is stimulated by m2 and m3 mAChRs in HEK-293 cells.
[Ca 2⍣ ] i increase by microinjected SPP in HEK-293 cells Finally, we investigated whether microinjected SPP was able to release Ca 2ϩ from intracellular stores in HEK-293 cells. To ensure that Ca 2ϩ mobilization did not occur via activation of the SPP receptor in the plasma membrane of HEK-293 cells as described previously Figure 6C and D) . Pretreatment of the cells 
Discussion
Here, we provide compelling evidence that Ca 2ϩ signalling by mAChRs in HEK-293 cells involves the activation of sphingosine kinase and the formation of SPP as second messenger. First, pretreatment of HEK-293 cells with two distinct inhibitors of sphingosine kinase, DHS and DMS, potently reduced m2 and m3 mAChR-induced increases in [Ca 2ϩ ] i , with IC 50 values in the ranges of those described for the inhibition of sphingosine kinase activity (Buehrer and Bell, 1992; Olivera and Spiegel, 1993; Olivera et al., 1994; Choi et al., 1996; Yatomi et al., 1996) . Control experiments excluded the possibility that suppression of Ca 2ϩ signalling by DHS and DMS was caused by a reduction in agonist-mAChR binding, G-protein activation, depletion of internal Ca 2ϩ stores, disruption of the cytoskeleton or inhibition of protein kinase C. cultured arterial smooth muscle cells (Olivera et al., 1993; Bornfeldt et al., 1995) , as well as FcεRI receptors in RBL-2H3 mast cells (Choi et al., 1996) , i.e. 40-120% and 60-100%, respectively. Furthermore, mAChR-induced sphingosine kinase activation was abolished by pretreatment of the cells with DHS or DMS. Finally, injection of SPP into HEK-293 cells caused release of Ca 2ϩ from internal stores in a heparin-insensitive manner, with a time course and magnitude comparable with that following injection of IP 3 . Sphingosine kinase was stimulated by both m2 and m3 mAChRs in HEK-293 cells, and Ca 2ϩ signalling by both mAChR subtypes was sensitive to inhibition by DHS and DMS. Moreover, Ca 2ϩ signalling by bradykinin receptors, which strongly activate PLC (Meyer zu Lümmen et al., 1997) , was inhibited significantly by DHS, at least in J82 transitional-cell carcinoma and opossum kidney cells. Thus, the sphingosine kinase pathway is apparently utilized, not only by GPCRs which couple inefficiently to PLC, but also by those which strongly activate PLC. However, the contribution of the sphingosine kinase pathway to overall Ca 2ϩ signalling was larger for the m2 mAChR, which weakly activates PLC, and smaller for the m3 mAChR, which strongly stimulates formation of IP 3 to trigger Ca 2ϩ release. As illustrated in Figure 4 , the level of m3 mAChR agonist activation apparently determined the Ca 2ϩ signalling pathway used, i.e. the sphingosine kinase-SPP pathway at low agonist occupancy, and the PLC-IP 3 pathway at high agonist occupancy. This may help to explain the discrepancy often observed with GPCRs, that at low agonist concentrations, even in the absence of measurable inositol phosphate production, Ca 2ϩ mobilization is nevertheless stimulated. Recently, Choi et al. (1996) reported that in m1 mAChR-transfected RBL-2H3 mast cells, Ca 2ϩ signals induced by 100 μM carbachol were unaffected by pretreatment with DHS, while Ca 2ϩ responses following FcεRI antigen receptor stimulation were blunted significantly. This observation led the authors to propose that Ca 2ϩ signalling by m1 mAChRs is sphingosine kinase-independent. However, similar to m3 mAChRs in HEK-293 cells, m1 mAChRs in mast cells couple efficiently to PLC. Thus, the carbachol concentration of 100 μM was apparently too high to detect involvement of sphingosine kinase in m1 mAChR-mediated Ca 2ϩ signalling.
We also demonstrate that Ca 2ϩ signalling by GPCRs can be independent of sphingosine kinase activation. For example, [Ca 2ϩ ] i increases induced by thrombin in J82 cells and by bradykinin in bovine aortic endothelial cells were not inhibited by DHS. Recently, Sugawara et al. (1997) demonstrated in B-cell-derived DT40 cells, in which all three types of IP 3 receptors had been deleted, that Ca 2ϩ mobilization by transfected m1 mAChRs was abolished completely. Thus, a second messenger function of SPP in Ca 2ϩ signalling by GPCRs may be not only receptor-specific but also dependent on the cell type, for example absent in some cells such as DT40 B cells and bovine aortic endothelial cells. However, the study by Sugawara et al. (1997) may indicate that an intact IP 3 signalling pathway is required for sphingosine kinasemediated Ca 2ϩ mobilization. At present, it is not clear whether the PLC-IP 3 and the sphingosine kinase-SPP pathways are fully independent Ca 2ϩ signalling pathways. As IP 3 and SPP are generated in a similar time-frame, there may be a concerted action of SPP and IP 3 in releasing Ca 2ϩ from internal stores.
Other open questions to be addressed in future studies are the mechanisms and signalling components by which plasma membrane receptors, tyrosine kinase receptors and GPCRs, activate sphingosine kinase. There may be multiple forms of sphingosine kinase, as sphingosine kinase activity has been shown to exist in both cytosolic (Louie et al., 1974; Olivera and Spiegel, 1994) and membrane-associated fractions (Buehrer and Bell, 1992; Ghosh et al., 1994) . Also, the exact intracellular target of SPP in HEK-293 cells is currently unknown. It is likely that SPP operates by activating the putative sphingolipidgated Ca 2ϩ channel in the endoplasmic reticulum (Ghosh et al., 1990 (Ghosh et al., , 1994 Mattie et al., 1994) . Our data add further evidence for the notion that SPP is a versatile molecule, acting as a primary messenger stimulating highaffinity plasma membrane receptors coupled to heterotrimeric G-proteins Meyer zu Heringdorf et al., 1996; Postma et al., 1996; van Koppen et al., 1996) , as well as fulfilling the role of a second messenger that stimulates a putative Ca 2ϩ channel in the endoplasmic reticulum.
In conclusion, this study demonstrates for the first time that the Ca 2ϩ signalling pathway based on sphingosine kinase activation is not restricted to tyrosine kinase-linked receptors but is also used by members of the GPCR superfamily in a cell type-dependent manner. As both IP 3 and SPP are generated upon GPCR stimulation within a similar time frame, cells can apparently utilize both pathways to mobilize Ca 2ϩ from internal stores. Contribution of sphingosine kinase to overall Ca 2ϩ signalling is apparently dependent on the coupling selectivity of the respective receptor, which in turn is dependent on the level of receptor activation. Since GPCRs constitute the largest family of membrane receptors and regulate numerous cellular processes by increasing [Ca 2ϩ ] i , the present findings are of far-reaching and immediate significance. [Ca 2⍣ ] i measurements HEK-293 cells stably expressing human m2 or m3 mAChRs were cultured in DME-F12 medium containing 10% fetal calf serum, 100 U/ml penicillin G and 0.1 mg/ml streptomycin (Schmidt et al., 1995) . [Ca 2ϩ ] i was determined using the fluorescent calcium indicator dye fura-2 (Molecular Probes) in a Hitachi spectrofluorimeter as described previously (Meyer zu . Briefly, cells were loaded with 3 μM fura-2-AM for 1 h at 37°C in PBS (137 mM NaCl, 3 mM KCl, 1 mM CaCl 2 , 1 mM MgCl 2 , 7 mM Na 2 HPO 4 , 2 mM KH 2 PO 4 , 1 mg/ml BSA and 5 mM glucose pH 7.4). Thereafter, cells were washed twice, resuspended in fresh buffer and used for fluorescence measurements within the next hour.
Materials and methods

Materials
PLC assay
PLC activity in HEK-293 cells was determined as described previously (Schmidt et al., 1995) . In brief, after labelling for 48 h with myo-[ 3 H]inositol (2.5 μCi/ml), cells were equilibrated for 10 min at 37°C in 1 ml HBSS (118 mM NaCl, 15 mM HEPES, 5 mM KCl, 1 mM CaCl 2 , 1 mM MgCl 2 and 5 mM glucose pH 7.4) containing 1 mg/ml BSA with or without DHS (30 μM) or DMS (15 μM). Cells were then incubated with carbachol at 37°C for either 15 s, to measure formation of [ 3 H]IP 3 , or 30 min in the presence of 10 mM LiCl, to measure formation of total [ 3 H]inositol phosphates. The reactions were stopped and labelled phospholipids and inositol phosphates were analysed as described previously (Schmidt et al., 1995) .
Measurement of [ 3 H]SPP formation
HEK-293 cells, on 35 mm plates, were equilibrated in 1 ml of 25 mM HEPES-buffered DME-F12 medium pH 7.4, containing 1 mg/ml fattyacid-free BSA for 10 min at 37°C. The reactions were started by the addition of 100 μl medium containing [ 3 H]sphingosine (~200 000 c.p.m., final concentration~15 nM), carbachol (final concentration either 0.3 or 100 μM) and 1 mg/ml fatty-acid-free BSA. Following incubation at 37°C for the indicated times, the medium was rapidly removed and 0.5 ml of ice-cold methanol was added to the plates. The cells were scraped into polypropylene tubes, and the plates were rinsed a second time with 0.5 ml methanol. One millilitre of chloroform together with 1 ml methanol were added to the tubes. After vortexing at high speed for 10 s, samples were centrifuged at 2000 g for 10 min to remove any particulate matter. The pellets were re-extracted with 3 ml chloroform:methanol (1:2), and the pooled supernatants were evaporated to dryness in a Speedvac centrifuge. After redissolving in methanol, samples were spotted onto Silica gel 60 TLC plates (E.Merck). Authentic sphingosine and SPP were applied with the samples for identification of [ 3 H]SPP and [ 3 H]sphingosine. Separation of the products was achieved by TLC in 1-butanol:acetic acid:water (3:1:1) as solvent system. Sphingosine (R f 0.67) and SPP (R f 0.51) spots were visualized with ninhydrin (staining sphingosine and SPP) and molybdenum blue (staining SPP 
Microinjection and [Ca 2⍣ ] i imaging
Following pretreatment with 75 ng/ml PTX for 16 h (to block G-proteincoupled SPP receptors in the plasma membrane), HEK-293 cells, on 35 mm dishes, were loaded for 60 min at 37°C with 3 μM fura-2-AM in 25 mM HEPES-buffered DME-F12 medium. After washing, cells were transferred for Ca 2ϩ imaging to the thermostatted stage of an inverted Zeiss Axiovert 100 fluorescence microscope heated to 37°C. Fluorescence measurements were performed using the Attofluor digital fluorescence imaging system (Atto Instruments). Cytosolic [Ca 2ϩ ] i was determined by ratio imaging of fura-2 fluorescence, using excitation wavelengths of 340 and 380 nm and an emission wavelength of 520 nm. The data sampling rate was usually a single ratio measurement every 5 s. Regions of interest were defined to cover as much of the area of each single cell as possible, and mean ratios were calculated for each region using software supplied by the manufacturer. Extracellular SPP, EGTA or DHS was added in 25 mM HEPES-buffered DME-F12 medium. The compounds to be injected were diluted in 27 mM K 2 HPO 4 , 8 mM Na 2 HPO 4 , 26 mM KH 2 PO 4 and 1 mg/ml BSA pH 7.2. Microinjection of samples in Femtotips II (Eppendorf) was performed with an Eppendorf micromanipulator type 5171 system with a transjector type 5246. The system was run in the semiautomatic mode with the following instrumental set-up conditions: pipette angle 45°, injection pressure 80 hPa, injection time 0.1 s and velocity of the pipette 700 μm/s.
